Eric E. Williams is a partner in the Indianapolis office of Barnes & Thornburg LLP and a member of the firm’s Intellectual Property Law Department. His practice is focused on preparing and prosecuting patent applications through the United States Patent and Trademark Office and counseling clients on the protection of intellectual property. He is a member of the firm’s Food, Drug, and Device Law Practice Group, and in this regard has provided advice to multiple clients in the pharmaceutical industry and prepared patent term extension (PTE) applications for FDA-approved products. He is also a member of the firm’s Higher Education Practice Group, and has worked extensively to advise both U.S.-based and international universities on protecting their intellectual property.
Dr. Williams received his Doctor of Pharmacy degree from Purdue University in 2003 where he was a member of the Rho Chi Pharmacy Honor Society. At Purdue, he conducted research on the ErbB family of tyrosine kinase receptors. He is the co-author of four journal articles and several symposium abstracts published from this research.
Upon graduation, Dr. Williams spent two years as a postdoctoral fellow in clinical research at the University of North Carolina-Chapel Hill and GlaxoSmithKline. At GlaxoSmithKline, he participated in the design of Phase II/III clinical trials in the neuroscience therapeutic area, including interactions with the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (formerly EMEA). Dr. Williams also has experience as a medical information associate for Eli Lilly and Company.
Dr. Williams earned his J.D., magna cum laude, in 2009 from Indiana University Robert H. McKinney School of Law. His student note, “Patent Reform: The Pharmaceutical Industry Prescription for Post-Grant Opposition and Remedies,” was published in the Journal of the Patent and Trademark Office Society.